About shionogi & co. ltd. - SGIOF
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.
SGIOF At a Glance
Shionogi & Co., Ltd.
3-1-8 Dosho-machi
Osaka, Osaka 541-0045
| Phone | 81-6-6202-2161 | Revenue | 3.01B | |
| Industry | Pharmaceuticals: Major | Net Income | 1.12B | |
| Sector | Health Technology | Employees | 4,959 | |
| Fiscal Year-end | 03 / 2025 | |||
| View SEC Filings |
SGIOF Valuation
| P/E Current | 10.941 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 13.258 |
| Price to Sales Ratio | 4.939 |
| Price to Book Ratio | 1.779 |
| Price to Cash Flow Ratio | 13.928 |
| Enterprise Value to EBITDA | 9.666 |
| Enterprise Value to Sales | 4.216 |
| Total Debt to Enterprise Value | 0.006 |
SGIOF Efficiency
| Revenue/Employee | 606,737.44 |
| Income Per Employee | 225,957.161 |
| Receivables Turnover | 3.707 |
| Total Asset Turnover | 0.313 |
SGIOF Liquidity
| Current Ratio | 5.856 |
| Quick Ratio | 5.372 |
| Cash Ratio | 2.674 |
SGIOF Profitability
| Gross Margin | 84.832 |
| Operating Margin | 39.409 |
| Pretax Margin | 45.602 |
| Net Margin | 37.241 |
| Return on Assets | 11.661 |
| Return on Equity | 13.642 |
| Return on Total Capital | 13.60 |
| Return on Invested Capital | 13.554 |
SGIOF Capital Structure
| Total Debt to Total Equity | 0.941 |
| Total Debt to Total Capital | 0.932 |
| Total Debt to Total Assets | 0.82 |
| Long-Term Debt to Equity | 0.709 |
| Long-Term Debt to Total Capital | 0.702 |